| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Friberg Gregory R | EVP, Chief R&D Officer | C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL | /s/ Tae Sang Yoo, Attorney-in-Fact | 02 Oct 2025 | 0002038768 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BMRN | Common Stock | Tax liability | $178,945 | -3,304 | -7.1% | $54.16 | 43,506 | 30 Sep 2025 | Direct |